MedPath

EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing cystectomy. The ENHANCE randomized controlled trial.

Recruiting
Conditions
bladder tumor
bladder cancer
10038364
Registration Number
NL-OMON54317
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
154
Inclusion Criteria

patients who have histologically confirmed, primary, bladder cancer
(cTa-4N0/N+M0)

Exclusion Criteria

Patients with severe cognitive or psychiatric disorders; patients who are
operated within 3 week; patients with insufficient command of the Dutch
language, which precludes them from following study instructions or completing
study questionnaires; patients who have contraindications to safely perform
exercise training or testing, and; patients who express the intention to follow
a similar exercise training programme regardless of randomisation outcome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The number of perioperative complications (grade 2 or higher) in the first 90<br /><br>days following surgery.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The number of high-grade (grade 3 or higher) complications, length of hospital<br /><br>stay, number of readmissions, improvement over time (pre- to post surgery) in<br /><br>cardiorespiratory fitness, physical functioning, nutritional status and a<br /><br>number of patient-reported outcomes (health-related quality of life, anxiety<br /><br>and depression, fatigue, levels of physical activity), changes in tumor hypoxia<br /><br>and health care costs.</p><br>
© Copyright 2025. All Rights Reserved by MedPath